190 related articles for article (PubMed ID: 34898573)
1. Association of Melanoma-Risk Variants with Primary Melanoma Tumor Prognostic Characteristics and Melanoma-Specific Survival in the GEM Study.
Davari DR; Orlow I; Kanetsky PA; Luo L; Busam KJ; Sharma A; Kricker A; Cust AE; Anton-Culver H; Gruber SB; Gallagher RP; Zanetti R; Rosso S; Sacchetto L; Dwyer T; Gibbs DC; Ollila DW; Begg CB; Berwick M; Thomas NE
Curr Oncol; 2021 Nov; 28(6):4756-4771. PubMed ID: 34898573
[TBL] [Abstract][Full Text] [Related]
2. Disease-Associated Risk Variants in
Davari DR; Orlow I; Kanetsky PA; Luo L; Edmiston SN; Conway K; Parrish EA; Hao H; Busam KJ; Sharma A; Kricker A; Cust AE; Anton-Culver H; Gruber SB; Gallagher RP; Zanetti R; Rosso S; Sacchetto L; Dwyer T; Ollila DW; Begg CB; Berwick M; Thomas NE;
Cancer Epidemiol Biomarkers Prev; 2021 Dec; 30(12):2309-2316. PubMed ID: 34607836
[TBL] [Abstract][Full Text] [Related]
3. Association of Interferon Regulatory Factor-4 Polymorphism rs12203592 With Divergent Melanoma Pathways.
Gibbs DC; Orlow I; Bramson JI; Kanetsky PA; Luo L; Kricker A; Armstrong BK; Anton-Culver H; Gruber SB; Marrett LD; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Sharma A; La Pilla E; From L; Busam KJ; Cust AE; Ollila DW; Begg CB; Berwick M; Thomas NE;
J Natl Cancer Inst; 2016 Jul; 108(7):. PubMed ID: 26857527
[TBL] [Abstract][Full Text] [Related]
4. Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma.
Thomas NE; Edmiston SN; Alexander A; Groben PA; Parrish E; Kricker A; Armstrong BK; Anton-Culver H; Gruber SB; From L; Busam KJ; Hao H; Orlow I; Kanetsky PA; Luo L; Reiner AS; Paine S; Frank JS; Bramson JI; Marrett LD; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Cust AE; Ollila DW; Begg CB; Berwick M; Conway K;
JAMA Oncol; 2015 Jun; 1(3):359-68. PubMed ID: 26146664
[TBL] [Abstract][Full Text] [Related]
5. Tumor-infiltrating lymphocyte grade in primary melanomas is independently associated with melanoma-specific survival in the population-based genes, environment and melanoma study.
Thomas NE; Busam KJ; From L; Kricker A; Armstrong BK; Anton-Culver H; Gruber SB; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Venn A; Kanetsky PA; Groben PA; Hao H; Orlow I; Reiner AS; Luo L; Paine S; Ollila DW; Wilcox H; Begg CB; Berwick M
J Clin Oncol; 2013 Nov; 31(33):4252-9. PubMed ID: 24127443
[TBL] [Abstract][Full Text] [Related]
6. Genetic variants in PARP1 (rs3219090) and IRF4 (rs12203592) genes associated with melanoma susceptibility in a Spanish population.
Peña-Chilet M; Blanquer-Maceiras M; Ibarrola-Villava M; Martinez-Cadenas C; Martin-Gonzalez M; Gomez-Fernandez C; Mayor M; Aviles JA; Lluch A; Ribas G
BMC Cancer; 2013 Mar; 13():160. PubMed ID: 23537197
[TBL] [Abstract][Full Text] [Related]
7. Inherited genetic variants associated with occurrence of multiple primary melanoma.
Gibbs DC; Orlow I; Kanetsky PA; Luo L; Kricker A; Armstrong BK; Anton-Culver H; Gruber SB; Marrett LD; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Sharma A; La Pilla E; From L; Busam KJ; Cust AE; Ollila DW; Begg CB; Berwick M; Thomas NE;
Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):992-7. PubMed ID: 25837821
[TBL] [Abstract][Full Text] [Related]
8. Inherited variation at MC1R and histological characteristics of primary melanoma.
Taylor NJ; Busam KJ; From L; Groben PA; Anton-Culver H; Cust AE; Begg CB; Dwyer T; Gallagher RP; Gruber SB; Orlow I; Rosso S; Thomas NE; Zanetti R; Rebbeck TR; Berwick M; Kanetsky PA
PLoS One; 2015; 10(3):e0119920. PubMed ID: 25790105
[TBL] [Abstract][Full Text] [Related]
9. Tumor-infiltrating lymphocytes predict cutaneous melanoma survival.
Fortes C; Mastroeni S; Mannooranparampil TJ; Passarelli F; Zappalà A; Annessi G; Marino C; Caggiati A; Russo N; Michelozzi P
Melanoma Res; 2015 Aug; 25(4):306-11. PubMed ID: 25933208
[TBL] [Abstract][Full Text] [Related]
10. Expression of lymphocyte-activating gene 3 and T-cell immunoreceptor with immunoglobulin and ITIM domains in cutaneous melanoma and their correlation with programmed cell death 1 expression in tumor-infiltrating lymphocytes.
Lee WJ; Lee YJ; Choi ME; Yun KA; Won CH; Lee MW; Choi JH; Chang SE
J Am Acad Dermatol; 2019 Jul; 81(1):219-227. PubMed ID: 30880064
[TBL] [Abstract][Full Text] [Related]
11. Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma.
Taylor RC; Patel A; Panageas KS; Busam KJ; Brady MS
J Clin Oncol; 2007 Mar; 25(7):869-75. PubMed ID: 17327608
[TBL] [Abstract][Full Text] [Related]
12. Tumor-associated B cells in cutaneous primary melanoma and improved clinical outcome.
Garg K; Maurer M; Griss J; Brüggen MC; Wolf IH; Wagner C; Willi N; Mertz KD; Wagner SN
Hum Pathol; 2016 Aug; 54():157-64. PubMed ID: 27107457
[TBL] [Abstract][Full Text] [Related]
13. Genetic variants in the metzincin metallopeptidase family genes predict melanoma survival.
Xu Y; Wang Y; Liu H; Shi Q; Zhu D; Amos CI; Fang S; Lee JE; Hyslop T; Li X; Han J; Wei Q
Mol Carcinog; 2018 Jan; 57(1):22-31. PubMed ID: 28796414
[TBL] [Abstract][Full Text] [Related]
14. Assessing the Prognostic Significance of Tumor-Infiltrating Lymphocytes in Patients With Melanoma Using Pathologic Features Identified by Natural Language Processing.
Yang J; Lian JW; Chin YH; Wang L; Lian A; Murphy GF; Zhou L
JAMA Netw Open; 2021 Sep; 4(9):e2126337. PubMed ID: 34550383
[TBL] [Abstract][Full Text] [Related]
15. Biologic and prognostic significance of dermal Ki67 expression, mitoses, and tumorigenicity in thin invasive cutaneous melanoma.
Gimotty PA; Van Belle P; Elder DE; Murry T; Montone KT; Xu X; Hotz S; Raines S; Ming ME; Wahl P; Guerry D
J Clin Oncol; 2005 Nov; 23(31):8048-56. PubMed ID: 16258103
[TBL] [Abstract][Full Text] [Related]
16. Mitotic rate is a more reliable unfavorable prognosticator than ulceration for early cutaneous melanoma: a 5-year survival analysis.
Donizy P; Kaczorowski M; Leskiewicz M; Zietek M; Pieniazek M; Kozyra C; Halon A; Matkowski R
Oncol Rep; 2014 Dec; 32(6):2735-43. PubMed ID: 25310673
[TBL] [Abstract][Full Text] [Related]
17. BILLCD8 - A Multivariable Survival Model as a Simple and Clinically Useful Prognostic Tool to Identify High-risk Cutaneous Melanoma Patients.
Donizy P; Biecek P; Halon A; Matkowski R
Anticancer Res; 2016 Sep; 36(9):4739-47. PubMed ID: 27630321
[TBL] [Abstract][Full Text] [Related]
18. Genetic variants in PDSS1 and SLC16A6 of the ketone body metabolic pathway predict cutaneous melanoma-specific survival.
Dai W; Liu H; Chen K; Xu X; Qian D; Luo S; Amos CI; Lee JE; Li X; Nan H; Li C; Wei Q
Mol Carcinog; 2020 Jun; 59(6):640-650. PubMed ID: 32232919
[TBL] [Abstract][Full Text] [Related]
19. No prognostic value added by vitamin D pathway SNPs to current prognostic system for melanoma survival.
Luo L; Orlow I; Kanetsky PA; Thomas NE; Fang S; Lee JE; Berwick M; Lee JH;
PLoS One; 2017; 12(3):e0174234. PubMed ID: 28323902
[TBL] [Abstract][Full Text] [Related]
20. Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma.
Azimi F; Scolyer RA; Rumcheva P; Moncrieff M; Murali R; McCarthy SW; Saw RP; Thompson JF
J Clin Oncol; 2012 Jul; 30(21):2678-83. PubMed ID: 22711850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]